Pathogenesis and management of bone lesions in multiple myeloma

被引：51

作者：

Bataille, R

Manolagas, SC

Berenson, JR

机构：

[1] UNIV ARKANSAS MED SCI HOSP, CTR OSTEOPOROSIS & METAB BONE DIS, LITTLE ROCK, AR 72205 USA

[2] W LOS ANGELES VET AFFAIRS MED CTR, LOS ANGELES, CA 90073 USA

[3] UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA 90024 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1997年 / 11卷 / 02期

关键词：

D O I：

10.1016/S0889-8588(05)70435-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Osteolytic lesions are among the hallmarks of multiple myeloma (MM). On the other hand, they are rare in B cell malignancies other than MM. Data have shown a close relationship between myeloma cell. growth factors and factors involved in the occurrence of bone lesions in MM. Biophosphonates, which are potent inhibitors of bone resorption to control MM-induced hypercalcemia, are of interest due to their ability to slow the progression of MM bone disease.

引用

页码：349 / +

页数：1

共 84 条

[11]

2-S

[12]

BATAILLE R, 1990, CANCER-AM CANCER SOC, V66, P167, DOI 10.1002/1097-0142(19900701)66:1<167::AID-CNCR2820660130>3.0.CO

[13]

2-9

[14] EFFECT OF DAILY ETIDRONATE ON THE OSTEOLYSIS OF MULTIPLE-MYELOMA [J].

BELCH, AR ;

BERGSAGEL, DE ;

WILSON, K ;

OREILLY, S ;

WILSON, J ;

SUTTON, D ;

PATER, J ;

JOHNSTON, D ;

ZEE, B .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) :1397-1402

[15]

Berenson J., 1995, Blood, V86, p442A

[16] Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].

Berenson, JR ;

Lichtenstein, A ;

Porter, L ;

Dimopoulos, MA ;

Bordoni, R ;

George, S ;

Lipton, A ;

Keller, A ;

Ballester, O ;

Kovacs, MJ ;

Blacklock, HA ;

Bell, R ;

Simeone, J ;

Reitsma, DJ ;

Heffernan, M ;

Seaman, J ;

Knight, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493

[17] CHINESE-HAMSTER OVARIAN-CELLS TRANSFECTED WITH THE MURINE INTERLEUKIN-6 GENE CAUSE HYPERCALCEMIA AS WELL AS CACHEXIA, LEUKOCYTOSIS AND THROMBOCYTOSIS IN TUMOR-BEARING NUDE-MICE [J].

BLACK, K ;

GARRETT, IR ;

MUNDY, GR .

ENDOCRINOLOGY, 1991, 128 (05) :2657-2659

[18]

BORSET M, 1993, BRIT J HAEMATOL, V85, P446

[19]

BOT FJ, 1989, BLOOD, V73, P435

[20] THE ROLE OF INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-ALPHA IN HUMAN MULTIPLE-MYELOMA [J].

CARTER, A ;

MERCHAV, S ;

SILVIANDRAXLER, I ;

TATARSKY, I .

BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (04) :424-431

← 1 2 3 4 5 6 7 8 9 →